• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单克隆抗体A7-超顺磁性氧化铁作为直肠癌磁共振成像造影剂

Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma.

作者信息

Toma A, Otsuji E, Kuriu Y, Okamoto K, Ichikawa D, Hagiwara A, Ito H, Nishimura T, Yamagishi H

机构信息

Department of Surgery, Kyoto Prefectural University of Medicine, 465 Kawaramachi Hirokoji Kamigyo-ku, Kyoto 602-8566, Japan.

出版信息

Br J Cancer. 2005 Jul 11;93(1):131-6. doi: 10.1038/sj.bjc.6602668.

DOI:10.1038/sj.bjc.6602668
PMID:15970924
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2361484/
Abstract

Superparamagnetic iron oxide (SPIO)-based colloid has been used clinically as a tissue-specific magnetic resonance contrast agent. We coupled monoclonal antibody A7 (Mab A7), which reacts specifically with human colorectal carcinoma, to Ferumoxides (SPIO) and examined the accumulation of this conjugate in xenografted tumours in nude mice. We examined in vitro immunoreactivity of Mab A7 coupled to Ferumoxides and its in vivo distribution in nude mice with human colorectal carcinoma. Magnetic resonance imaging of tumour-bearing nude mice was performed 72 h after injection of A7-Ferumoxides. A7-Ferumoxides retained binding activities that were nearly identical to intact Mab A7. More of the radiolabelled A7-Ferumoxides accumulated in the tumour than normal mouse IgG-Ferumoxides from 12 h onwards after injection (P<0.05). Both A7-Ferumoxides and normal mouse IgG-Ferumoxides disappeared from blood linearly over time. The accumulation levels in normal tissue decreased linearly over time but were lower than levels in tumours from 6 h. In magnetic resonance T2-weighted imaging of the tumour-bearing nude mice, signal intensity was reduced at the margin of the tumour by injection of A7-Ferumoxides. Mab A7 coupled to Ferumoxides is potentially suitable as a magnetic resonance contrast agent for detecting local recurrence of rectal carcinoma.

摘要

基于超顺磁性氧化铁(SPIO)的胶体已在临床上用作组织特异性磁共振造影剂。我们将与人结肠直肠癌特异性反应的单克隆抗体A7(Mab A7)与菲立磁(SPIO)偶联,并检测了该缀合物在裸鼠异种移植肿瘤中的蓄积情况。我们检测了与菲立磁偶联的Mab A7的体外免疫反应性及其在患有人类结肠直肠癌的裸鼠体内的分布。在注射A7-菲立磁72小时后,对荷瘤裸鼠进行磁共振成像。A7-菲立磁保留了与完整Mab A7几乎相同的结合活性。注射后12小时起,肿瘤中积聚的放射性标记A7-菲立磁比正常小鼠IgG-菲立磁更多(P<0.05)。A7-菲立磁和正常小鼠IgG-菲立磁在血液中的含量均随时间呈线性下降。正常组织中的蓄积水平随时间呈线性下降,但从6小时起低于肿瘤中的水平。在荷瘤裸鼠的磁共振T2加权成像中,注射A7-菲立磁后肿瘤边缘的信号强度降低。与菲立磁偶联的Mab A7有可能适合作为检测直肠癌局部复发的磁共振造影剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3429/2361484/019481298674/93-6602668f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3429/2361484/2b36c46d6c6d/93-6602668f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3429/2361484/996b40d0f9b8/93-6602668f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3429/2361484/edf73165274e/93-6602668f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3429/2361484/9ecbc999504f/93-6602668f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3429/2361484/11f32df3c003/93-6602668f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3429/2361484/019481298674/93-6602668f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3429/2361484/2b36c46d6c6d/93-6602668f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3429/2361484/996b40d0f9b8/93-6602668f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3429/2361484/edf73165274e/93-6602668f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3429/2361484/9ecbc999504f/93-6602668f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3429/2361484/11f32df3c003/93-6602668f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3429/2361484/019481298674/93-6602668f6.jpg

相似文献

1
Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma.单克隆抗体A7-超顺磁性氧化铁作为直肠癌磁共振成像造影剂
Br J Cancer. 2005 Jul 11;93(1):131-6. doi: 10.1038/sj.bjc.6602668.
2
Monoclonal antibody A7 coupled to magnetic particles as a contrast enhancing agent for magnetic resonance imaging of human colorectal carcinoma.偶联磁性颗粒的单克隆抗体A7作为人结直肠癌磁共振成像的造影增强剂。
Cancer Immunol Immunother. 2006 Jun;55(6):728-33. doi: 10.1007/s00262-005-0067-9. Epub 2005 Nov 5.
3
Monoclonal antibody conjugated to gadolinium as a contrast agent for magnetic resonance imaging of human rectal carcinoma.钆缀合的单克隆抗体作为人直肠癌磁共振成像的造影剂。
J Surg Oncol. 2006 Aug 1;94(2):144-8. doi: 10.1002/jso.20411.
4
Local administration of monoclonal antibody-drug conjugate: a new strategy to reduce the local recurrence of colorectal cancer.单克隆抗体药物偶联物的局部给药:降低结直肠癌局部复发的新策略。
Cancer Res. 1992 Nov 15;52(22):6323-8.
5
Molecular Targeted Magnetic Resonance Imaging of Human Colorectal Carcinoma (LoVo) Cells Using Novel Superparamagnetic Iron Oxide- Loaded Nanovesicles: In Vitro and in vivo Studies.使用新型负载超顺磁性氧化铁的纳米囊泡对人结肠癌细胞(LoVo)进行分子靶向磁共振成像:体外和体内研究
Curr Cancer Drug Targets. 2016;16(6):551-60. doi: 10.2174/1568009616666160603123616.
6
Potential usefulness of 99mTc-labeled monoclonal antibody A7 for immunoscintigraphy of human pancreatic carcinoma.99mTc标记的单克隆抗体A7在人胰腺癌免疫闪烁显像中的潜在应用价值。
Anticancer Res. 2001 Sep-Oct;21(5):3433-7.
7
Enhanced tumor localization of radiolabeled Fab fragments of monoclonal antibody A7 in nude mice bearing human pancreatic carcinoma xenografts.单克隆抗体A7的放射性标记Fab片段在荷人胰腺癌异种移植瘤裸鼠中肿瘤定位增强。
Jpn J Cancer Res. 1993 Aug;84(8):914-20. doi: 10.1111/j.1349-7006.1993.tb02066.x.
8
Detection and characterization of focal liver lesions using superparamagnetic iron oxide-enhanced magnetic resonance imaging: comparison between ferumoxides-enhanced T1-weighted imaging and delayed-phase gadolinium-enhanced T1-weighted imaging.利用超顺磁性氧化铁增强磁共振成像检测和表征肝脏局灶性病变:菲立磁增强T1加权成像与钆剂延迟期增强T1加权成像的比较
Abdom Imaging. 2003 Jul-Aug;28(4):525-30. doi: 10.1007/s00261-002-0064-9.
9
Monoclonal antibody against antigen A7 coupled to ferromagnetic lignosite particles与铁磁性褐煤颗粒偶联的抗A7抗原单克隆抗体
10
Efficacy and specificity of a monoclonal antibody-drug conjugate in chemotherapy by intratumoral injection.一种单克隆抗体 - 药物偶联物瘤内注射化疗的疗效与特异性
Jpn J Cancer Res. 1992 Jul;83(7):769-74. doi: 10.1111/j.1349-7006.1992.tb01978.x.

引用本文的文献

1
Nanotechnology Advances in the Detection and Treatment of Cancer: An Overview.纳米技术在癌症检测和治疗中的应用进展:概述。
Nanotheranostics. 2022 Aug 21;6(4):400-423. doi: 10.7150/ntno.74613. eCollection 2022.
2
Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer.发现 HSPG2(Perlecan)作为三阴性乳腺癌的治疗靶点。
Sci Rep. 2019 Aug 28;9(1):12492. doi: 10.1038/s41598-019-48993-6.
3
Application of Nanotechnology in Targeting of Cancer Stem Cells: A Review.纳米技术在癌症干细胞靶向治疗中的应用:综述

本文引用的文献

1
Preparation of iodine-131 labelled human growth hormone of high specific activity.高比活度碘-131标记人生长激素的制备
Nature. 1962 May 5;194:495-6. doi: 10.1038/194495a0.
2
Total mesorectal excision for rectal cancer--what can be achieved by a national audit?直肠癌全直肠系膜切除术——全国性审计能达成什么目标?
Colorectal Dis. 2003 Sep;5(5):471-7. doi: 10.1046/j.1463-1318.2003.00506.x.
3
[Importance of CT and MRI in the follow-up of patients with rectal cancer].[CT和MRI在直肠癌患者随访中的重要性]
Int J Stem Cells. 2019 Jul 31;12(2):227-239. doi: 10.15283/ijsc19006.
4
Magnetic Nanoparticle Facilitated Drug Delivery for Cancer Therapy with Targeted and Image-Guided Approaches.磁性纳米颗粒促进药物递送用于靶向和图像引导的癌症治疗。
Adv Funct Mater. 2016 Jun 14;26(22):3818-3836. doi: 10.1002/adfm.201504185. Epub 2016 Feb 5.
5
Fabrication of mAb G250-SPIO molecular magnetic resonance imaging nanoprobe for the specific detection of renal cell carcinoma in vitro.用于体外特异性检测肾细胞癌的单克隆抗体G250-超顺磁性氧化铁分子磁共振成像纳米探针的制备
PLoS One. 2014 Jul 7;9(7):e101898. doi: 10.1371/journal.pone.0101898. eCollection 2014.
6
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation.靶向聚合物治疗纳米粒:设计、开发与临床转化。
Chem Soc Rev. 2012 Apr 7;41(7):2971-3010. doi: 10.1039/c2cs15344k. Epub 2012 Mar 5.
7
Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer.超顺磁性氧化铁纳米颗粒:癌症诊断与治疗的前景
Int J Mol Epidemiol Genet. 2011;2(4):367-90. Epub 2011 Nov 25.
8
Recent trends in antibody-based oncologic imaging.基于抗体的肿瘤影像学的最新趋势。
Cancer Lett. 2012 Feb 28;315(2):97-111. doi: 10.1016/j.canlet.2011.10.017. Epub 2011 Oct 20.
9
In vivo molecular targeting effects of anti-Sp17- ICG-Der-02 on hepatocellular carcinoma evaluated by an optical imaging system.光学成像系统评价抗 Sp17-ICG-Der-02 对肝癌的体内分子靶向作用。
J Exp Clin Cancer Res. 2011 Mar 3;30(1):25. doi: 10.1186/1756-9966-30-25.
10
Receptor-targeted nanocarriers for therapeutic delivery to cancer.用于癌症治疗递送的受体靶向纳米载体。
Mol Membr Biol. 2010 Oct;27(7):286-98. doi: 10.3109/09687688.2010.521200.
Radiologe. 2003 Feb;43(2):122-7. doi: 10.1007/s00117-002-0859-2.
4
Gadolinium-enhanced MRI with dynamic evaluation in diagnosing the local recurrence of rectal cancer.钆增强磁共振成像结合动态评估在直肠癌局部复发诊断中的应用
Abdom Imaging. 2003 Jan-Feb;28(1):19-27. doi: 10.1007/s00261-001-0127-3.
5
Decreased tumor cell proliferation as an indicator of the effect of preoperative radiotherapy of rectal cancer.肿瘤细胞增殖减少作为直肠癌术前放疗效果的一个指标。
Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):659-63. doi: 10.1016/s0360-3016(01)01515-2.
6
Combined chemo- and radiotherapy vs. radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum.化疗联合放疗与单纯放疗治疗原发性不可切除直肠癌的比较
Int J Radiat Oncol Biol Phys. 2001 Jun 1;50(2):427-34. doi: 10.1016/s0360-3016(01)01479-1.
7
Added value of CEA scintigraphy in the detection of recurrence of rectal carcinoma.
Acta Radiol. 2000 Nov;41(6):629-33. doi: 10.1034/j.1600-0455.2000.041006629.x.
8
Regional hyperthermia for rectal cancer.
Lancet. 2000 Aug 26;356(9231):771-2. doi: 10.1016/S0140-6736(05)73674-6.
9
Clinical assessment of positron emission tomography for the diagnosis of local recurrence in colorectal cancer.
Br J Surg. 1999 Jul;86(7):932-7. doi: 10.1046/j.1365-2168.1999.01178.x.
10
United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition).英国癌症研究协调委员会(UKCCCR)《实验性肿瘤学动物福利指南》(第二版)
Br J Cancer. 1998;77(1):1-10. doi: 10.1038/bjc.1998.1.